Inventaire - your friends and communities are your best library

Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome

Author

Matthias J. Schnell

James P McGettigan

Published in: Journal of Virology

Date of publication: October 1, 2003

Language: English

Main subject: HIV, vector-borne disease

Bibliographic databases:

Cites articles 55

Date

Title

Authors

February 1, 1981

Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription
January 1, 1983

Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus

,
August 1, 1988

Completion of the rabies virus genome sequence determination: highly conserved domains among the L (polymerase) proteins of unsegmented negative-strand RNA viruses
April 1, 1990

Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19.
December 1, 1991

Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein
December 1, 1992

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
January 1, 1992

Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells
December 1, 1993

The rabies virus genome: an overview
February 1, 1994

Rescue of synthetic genomic RNA analogs of rabies virus by plasmid-encoded proteins
September 1, 1994

Infectious rabies viruses from cloned cDNA
January 1995

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
July 1, 1996

Highly stable expression of a foreign gene from rabies virus vectors
July 1, 1997

Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins
April 1, 1997

HIV-1 antibody--debris or virion?
November 1, 1998

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

,
August 1, 1998

Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer

,
June 1, 1998

Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge,Vaccination with a Recombinant Vesicular Stomatitis Virus Expressing an Influenza Virus Hemagglutinin Provides Complete Protection from Influenza Virus Challenge
May 1, 1998

Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients,Cross-Reactions between the Cytotoxic T-Lymphocyte Responses of Human Immunodeficiency Virus-Infected African and European Patients
August 1, 1999

Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy
May 1, 1999

Virus promoters determine interference by defective RNAs: selective amplification of mini-RNA vectors and rescue from cDNA by a 3' copy-back ambisense rabies virus
May 1, 1999

Attenuated vesicular stomatitis viruses as vaccine vectors
January 1, 1999

Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter
January 1, 1999

Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G
December 1, 2000

A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection
September 1, 2000

Molecular biology of human immunodeficiency virus type 1.
March 1, 2000

Recombinant rabies virus as potential live-viral vaccines for HIV-1.
March 1, 2000

Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope
November 1, 2000

Potential live vaccines for HIV.
October 1, 2000

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

, , ,
September 1, 2001

Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector
June 1, 2001

Viral vectors as potential HIV-1 vaccines
May 1, 2001

Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates

Article -

Welcome to inventaire

The library of your friends and communities

Learn more